Research Article
Serum Neuropeptide Y: A Potential Prognostic Marker of Intracerebral Hemorrhage
Table 1
Baseline characteristics of ICH patients according to different prognosis at 3 months.
| Characteristics | 3-month prognosis | values | Good () | Poor () | |
| Demographics or anthropometrics | | | | Age (years) | | | 0.566 | Gender, male/female | 89/51 | 138/86 | 0.707 | Body mass index (kg/m2) | | | 0.581 | Medical history | | | | Hypertension | 81 | 135 | 0.649 | Diabetes mellitus | 30 | 52 | 0.692 | Hyperlipidemia | 76 | 118 | 0.765 | Coronary artery disease | 22 | 41 | 0.525 | Clinical severity | | | | NIHSS scores (points) | | | 0.036 | Hematoma volume (ml) | | | 0.039 | Laboratory data | | | | Total cholesterol (mmol/l) | | | 0.425 | Triglycerides (mmol/l) | | | 1.000 | LDL cholesterol (mmol/l) | | | 0.087 | HDL cholesterol (mmol/l) | | | 1.000 | Blood glucose (mmol/l) | | | 0.237 | Neuropeptide Y (ng/ml) | | | <0.001 |
|
|
NIHSS: National Institutes of Health Stroke Scale; LDL: low-density lipoprotein; HDL: high-density lipoprotein.
|